golimumab
English edit
Etymology edit
From [Term?] + -lim- (“immunomodulating”) + -umab (“human monoclonal antibody”).
(This etymology is missing or incomplete. Please add to it, or discuss it at the Etymology scriptorium.)
Pronunciation edit
- (General American) IPA(key): /ɡoʊˈlɪm.jəˌmæb/
Noun edit
golimumab (uncountable)
- (pharmacology) A genetically engineered monoclonal antibody (trademark Simponi) that inhibits the activity of tumor necrosis factor and is administered by subcutaneous injection to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis.
References edit
- “golimumab”, in Merriam-Webster Online Dictionary, Springfield, Mass.: Merriam-Webster, 1996–present.